ArQule Inc (ARQL.OQ)
ARQL.OQ on NASDAQ Stock Exchange Global Market
2.61USD
1:18pm EDT
2.61USD
1:18pm EDT
Price Change (% chg)
$-0.04 (-1.33%)
$-0.04 (-1.33%)
Prev Close
$2.64
$2.64
Open
$2.66
$2.66
Day's High
$2.69
$2.69
Day's Low
$2.60
$2.60
Volume
11,256
11,256
Avg. Vol
95,520
95,520
52-wk High
$6.97
$6.97
52-wk Low
$1.98
$1.98
About
ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. It employs technologies, such as its ArQule Kinase Inhibitor Platform to design and develop drugs. Its product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase (c-Met). C-Met is... (more)
Overall
| Beta: | 1.23 |
| Market Cap (Mil.): | $165.59 |
| Shares Outstanding (Mil.): | 62.72 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARQL.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 44.65 | 37.87 |
| EPS (TTM): | -0.29 | -- | -- |
| ROI: | -18.26 | -2.30 | 18.70 |
| ROE: | -23.57 | -2.12 | 19.53 |
Competitors
| Price | Change | |
|---|---|---|
| Takeda Pharmaceutical Company Limited (4502.T) | ¥4,635 | +55.00 |
| Pfizer Inc. (PFE.N) | $29.32 | +0.21 |
| Johnson & Johnson (JNJ.N) | $93.84 | +0.07 |
| Merck & Co., Inc. (MRK.N) | $48.32 | -0.26 |
| Roche Holding Ltd. (ROG.VX) | CHF228.70 | +0.70 |
| AstraZeneca plc (AZN.L) | 3,332.50p | -1.50 |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | 0.00 |
| Bristol Myers Squibb Co. (BMY.N) | $43.95 | -0.04 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 13,920.00₪ | -200.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$49.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

